Prevalence and Clinical Impact of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolated From Hospitalized Patients

BACKGROUND: We estimated the prevalence and clinical impact of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA). The concordance between macromethod and glycopeptide resistance detection (GRD) E tests was determined. In addition, predictors of clinical outcomes in hospitalized pat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Lab Med
Main Authors: Koh, Young Rae, Kim, Kye-Hyung, Chang, Chulhun L., Yi, Jongyoun
Formato: Artigo
Idioma:Inglês
Publicado: The Korean Society for Laboratory Medicine 2016
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4773264/
https://ncbi.nlm.nih.gov/pubmed/26915612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3343/alm.2016.36.3.235
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares